Coronary Artery Calcium Scoring Mirvat Alasnag FACP, FRCP, FSCCT, FSCAI, FASE King Fahd Armed Forces Hospital, Jeddah. March 2017

Similar documents
Coronary Artery Calcium. Vimal Ramjee, MD FACC The Chattanooga Heart Institute

New Paradigms in Predicting CVD Risk

Diagnostic and Prognostic Value of Coronary Ca Score

Financial Disclosures. Coronary Artery Calcification. Objectives. Coronary Artery Calcium 6/6/2018. Heart Disease Statistics At-a-Glace 2017

Preclinical Detection of CAD: Is it worth the effort? Michael H. Crawford, MD

Combining Coronary Artery Calcium Scanning with SPECT/PET Myocardial Perfusion Imaging

Risk Stratification for CAD for the Primary Care Provider

Short and Long Term Prognosis after Coronary Artery Calcium Scoring

Cardiac CT Angiography

Using Coronary Artery Calcium Score in the Quest for Cardiac Health. Robert J. Hage, D.O.

Subclinical atherosclerosis in CVD: Risk stratification & management Raul Santos, MD

2/20/2013. Why use imaging in CV prevention? Update on coronary CTA in 2013 Coronary CTA for 1 0 prevention: pros and cons Are we there yet?

Calcium scoring Clinical and prognostic value

Optimal testing for coronary artery disease in symptomatic and asymptomatic patients

MOHAMMED R. ESSOP DIVISION OF CARDIOLOGY CH-BARAGWANATH HOSPITAL

The role of coronary artery calcium score on the detection of subclinical atherosclerosis in metabolic diseases

CARDIAC IMAGING FOR SUBCLINICAL CAD

Dr Chris Ellis. Consultant Cardiologist Auckland City Hospital Auckland. 11:30-12:00 ECGs for Nurses, and The Basics of CT Heart Scanning

Landmesser U et al. Eur Heart J 2017; /eurheartj/ehx549

The International SHAPE Accreditation and Early Detection Program Report

Khurram Nasir, MD MPH

Cardiac CT for Risk Assessment: Do we need to look beyond Coronary Artery Calcification

The role of coronary artery calcium score on the detection of subclinical atherosclerosis in metabolic diseases

Dr Chris Ellis. Consultant Cardiologist Auckland

Potential recommendations for CT coronary angiography in athletes

Coronary Artery Calcification

Sanger Heart & Vascular Institute Symposium 2015

ACC/AHA GUIDELINES ON LIPIDS AND PCSK9 INHIBITORS

Management of Stable Ischemic Heart Disease. Vinay Madan MD February 10, 2018

LDL cholesterol (p = 0.40). However, higher levels of HDL cholesterol (> or =1.5 mmol/l [60 mg/dl]) were associated with less progression of CAC

Current Cholesterol Guidelines and Treatment of Residual Risk COPYRIGHT. J. Peter Oettgen, MD

NEW GUIDELINES FOR CHOLESTEROL

MEDICAL POLICY SUBJECT: CORONARY CALCIUM SCORING

Current and Future Imaging Trends in Risk Stratification for CAD

Treatment of Cardiovascular Risk Factors. Kevin M Hayes D.O. F.A.C.C. First Coast Heart and Vascular Center

MD F A F C A C MAS A N S C

MPS and Calcium Score in asymptomatic patient F. Mut, J. Vitola

BENEFIT APPLICATION BLUECARD/NATIONAL ACCOUNT ISSUES

Prevention of Heart Disease: The New Guidelines

Physical Activity and Coronary calcification ADJ ASSOCIATE PROFESSOR TAN SWEE YAW NATIONAL HEART CENTRE SINGAPORE

Diabetes and Occult Coronary Artery Disease

New Guidelines in Dyslipidemia Management

The Multiethnic Study of Atherosclerosis (MESA) Cardiovascular Risk in Hispanics

Testing the Asymptomatic CAD Patient: When and Why?

CVD Risk Assessment. Michal Vrablík Charles University, Prague Czech Republic

Are We Ready for a Paradigm Shift From Risk Factors to Detection of Subclinical Coronary Atherosclerosis? Lessons From MESA. Khurram Nasir, MD MPH

Εξελίξεις και νέες προοπτικές στην καρδιαγγειακή απεικόνιση CT. Σταμάτης Κυρζόπουλος Ωνάσειο Καρδιοχειρουργικό Κέντρο

How to Reduce Residual Risk in Primary Prevention

Richard Grocott Mason

1. Which one of the following patients does not need to be screened for hyperlipidemia:

MEDICAL POLICY. 02/15/18 CATEGORY: Technology Assessment

FFR-CT Not Ready for Primetime

David Ramenofsky, MD Bryan Kestenbaum, MD

Assessing atherosclerotic risk for long term preventive treatment

Screening for Cardiovascular Risk (2/6/09)

What s new in cardiovascular disease risk assessment and management for primary care clinicians

I have no financial disclosures

The presenter does not have any potential conflicts of interest to disclose

Disclosures. Prevention of Heart Disease: The New Guidelines. Summary of Talk. Four guidelines. No relevant disclosures.

Vascular calcification in patients with Diabetes Mellitus. Dr Jamie Bellinge University of Western Australia Royal Perth Hospital

SCAPIS. Swedish CArdioPulmonary BioImage Study. SCAPIS outline. one of the largest cardiopulmonary research programs in Sweden

Who Cares About the Past?

Report For Center Created Gender D.O.B Page 1 Sean Breen HeartSmart IMT plus 3/29/2012 Male 11/26/1973 B C D E

Conceptual Approach to CAD Risk. Disclosures. Integrating Imaging and Biomarkers for Optimal CVD Risk Assessment and Management 2/10/2014.

Vascular disease. Structural evaluation of vascular disease. Goo-Yeong Cho, MD, PhD Seoul National University Bundang Hospital

Atherosclerotic Disease Risk Score

Lifetime clinical and economic benefits of statin-based LDL lowering in the 20-year Followup of the West of Scotland Coronary Prevention Study

CLINICAL STUDY. Yasser Khalil, MD; Bertrand Mukete, MD; Michael J. Durkin, MD; June Coccia, MS, RVT; Martin E. Matsumura, MD

Η Πυρηνική Καρδιολογία Το 2017 ΟΜΑΔΑ ΕΡΓΑΣΙΑΣ ΑΠΕΙΚΟΝΙΣΤΙΚΩΝ ΤΕΧΝΙΚΩΝ

Carotid Ultrasound Scans for Assessing Cardiovascular Risk

Long-Term Complications of Diabetes Mellitus Macrovascular Complication

Carotid Ddisease, Carotid IMT and Risk of Stroke

ACCF/AHA Expert Consensus Document

Polish Your Practice Heart Failure. Why Prevent Vs. Treat? Coronary Heart Disease. A Challenging Patient:1994. Risk Factors for Heart Attack

Beyond Framingham. Prediction of cardiovascular risk. Niels van Pelt Cardiologist, Middlemore Hospital

To Do or Not To Do? The Annual Physical- Beyond The PAP And Breast Exam

Coronary Artery Calcium: Absence Makes the Heart Younger?

No relevant financial relationships

American Osteopathic College of Occupational and Preventive Medicine 2012 Mid-Year Educational Conference St. Petersburg, Florida

How would you manage Ms. Gold

CORONARY ARTERY CALCIUM AND INCIDENT STROKE IN THE MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (MESA) COHORT ASHLEIGH A. OWEN, MD

Review of guidelines for management of dyslipidemia in diabetic patients

Is computed tomography angiography really useful in. of coronary artery disease?

Role of Nonenhanced Multidetector CT Coronary Artery Calcium Testing in Asymptomatic and Symptomatic Individuals 1

Keywords Coronary artery calcium Coronary artery atherosclerosis Coronary risk assessment Coronary artery CT

Imaging of Coronary Arteries Aid in Prevention of Atherosclerosis and Clinical Coronary Heart Disease

Coronary Calcium Predicts Events Better With Absolute Calcium Scores Than Age-Sex-Race/Ethnicity Percentiles

When Should I Order a Stress Test or an Echocardiogram

2013 ACC/AHA Guidelines on the Assessment of Atherosclerotic Cardiovascular Risk: Overview and Commentary

Cardiovascular risk assessment in patients with diabetes

Prevention of MACROvascular Complications of Diabetes

Screening for Asymptomatic Coronary Artery Disease: When, How, and Why?

CARDIOMETABOLIC SYNDROME

Update on Lipid Management in Cardiovascular Disease: How to Understand and Implement the New ACC/AHA Guidelines

Review current guideline recommendations for lipid-lowering therapy

Dr Chris Ellis Cardiologist, Auckland City Hospital

Calcium Scoring and Cardiac CT

Treatment Considerations for Carotid Artery Stenosis. Danielle Zielinski, RN, MSN, ACNP Rush University Neurosurgery

CT Imaging of Atherosclerotic Plaque. William Stanford MD Professor-Emeritus Radiology University of Iowa College of Medicine Iowa City, IA

Dr Joan Leighton. Professor Gerry Devlin. 14:00-14:55 WS #106: Whats Topical in Cardiology 15:05-16:00 WS #116: Whats Topical in Cardiology (Repeated)

Transcription:

Coronary Artery Calcium Scoring Mirvat Alasnag FACP, FRCP, FSCCT, FSCAI, FASE King Fahd Armed Forces Hospital, Jeddah March 2017

Newspapers

Referrals 62 year old female CT chest and abdomen following an endoscopy for a suspicious mass No cardiac symptoms CAC score moderate Now what? CACS 100-300 then risk factor modification CACS > 300 ETT or CCTA Arterial calcification on mammography is a predictor >> recommend CAC score

1. Younger patients with family history of premature coronary heart disease, have significantly higher CACS.

1.

2. CAC scoring has consistently been associated with a greater precision than individual and combination of risk factors.

3. Second hand smoking & pollution from smoking has been associated with increased risk of coronary artery calcification, but not coronary artery disease.

4. Radiation exposure from a CAC scoring is higher than average annual background radiation in the USA, but less than that for a mammogram.

5. MESA reports the prevalence of CAC among intermediate risk individuals is 10% and very low risk individuals is 5%.

MESA SCORE: Multi-Ethnic Study of Atherosclerosis >300 Risk Equivalent (LDL < 70mg/dl) 100-300 Intermediate <100 Low

6. CAC scoring is highly predictive of coronary heart disease events across all age groups.

7. Men tend to have higher levels of calcium than women and the amount of calcium tends to increase with age. This difference is eliminated by age 75.

8. A CAC score higher than the 50 th percentile for one s age and sex is indicative of high risk clinically significant plaque and premature atherosclerosis.

9. Patients with a CAC score > 100 were 7-10x more likely to experience a coronary event over a median follow up of 3.9 years.

10. The value of a CAC score of ZERO has been confirmed in multiple high risk groups.

11. The annual rate of a coronary event in a patient with a CAC score of 0 is 0.11%.

12. A CAC score of 0 translates into a low 10-year risk of coronary heart events irrespective of risk factors.

13. In Diabetic patients, CAC scoring cannot identify those who are at low risk within this high risk population.

14. Higher CAC scores have only been associated with coronary heart events and not an increased risk of atrial fibrillation, heart failure or stroke.

15. CAC scoring is a stronger predictor of cardiovascular disease and coronary heart disease than carotid ultrasound measures.

Controversies with CAC: 1. A positive CAC score does not imply obstructive disease (+ ETT, MPI suggest high likelihood of stenosis ) Often CAC score is referrerd to as a test of atherosclerosis and not stenosis > > risk factor modification 2. CAC score of 0 Over 40 years risk of event/year is <1/1000 Soft plaque is not concerning & event rates higher with mixed or calcified plaque.

3. Who to screen for CAC? Low risk with FH of premature CAD, Lupus, HIV Intermediate risk: (5-20%/10 year event rate by 2013 pooled cohort equation) High risk: None >> test won t alter their risk as assessed by other calculators except in statin intolerant 4. De-escalation of therapy for 0 CAC score?

Warranty: Normal Coronary angiogram >>10 years CAC score 0 >> 15 years 5 easily 10 probably safe 15 years unless develop in the interim DM/HTN 9715 stratified by age, FRS, NCEP ATP III RESULTS: 4864 CAC 0 >>229 deaths CAC score strongest predictor of death CAC 0 associated with a low vascular age CONCLUSION: Mean follow up 14.6 yrs (12.9-16.8 ) A score of 0 confers a 15 year warranty in those at low intermediate risk unaffected by age and sex. High risk w CAC 0 confers better survival than those w lowintermediate risk & any score more than 0.

American College of Cardiology Foundation Amir A. Mahabadi et al. JIMG 2017;10:143-153

American College of Cardiology Foundation Amir A. Mahabadi et al. JIMG 2017;10:143-153

5 Trials for Primary Prevention of CVS Disease: 1. DIAD (Diagnostic Imaging in Asymptomatic Diabetics) 2. St Francis Heart Study 3. PACC (Prospective Army Coronary Calcium) 4. EISNER (Early Identification of Subclinical Atherosclerosis by Noninvasive Imaging Research) 5. FACTOR-64 6. KEEPS -Underpowered -Short follow up